Loading
institutionsInstitution
Wilmot Cancer Institute, University of Rochester
Upstate New York's Wilmot Cancer Institute, NCI-designated in 2024 and a national leader in geriatric oncology and cancer-control research.
Overview
Wilmot Cancer Institute at the University of Rochester Medical Center received NCI designation in 2024 and serves a largely rural 27-county region of upstate New York. It hosts one of the NCI Community Oncology Research Program's national research bases, historically led by Gary Morrow, whose trials on nausea, fatigue and exercise defined cancer-control research; Karen Mustian's exercise oncology and Supriya Mohile's geriatric assessment trials (GAP70+) showed that assessing older patients reduces chemotherapy toxicity. Jonathan Friedberg, editor-in-chief of the Journal of Clinical Oncology, leads its lymphoma programme. Director Jonathan Friedberg and cancer biologist Hartmut Land have built basic programmes in tumour evolution and haematologic malignancy.
Location
Rochester, NY, US
Type
cancer center · University of Rochester
Newsweek 2026 oncology rank
Not in top 300 listing used
NCI designation
clinical
OnCo score
#286 · 24 points (0 Newsweek + 8 NCI + 16 from 8 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-17.
Matched to University of Rochester, including child institutions. 861 works · 12,212 citations · 64% open access · 12% clinical trials · 3% reviews.
Oncology works per year
1752022
2122023
1722024
1752025
1272026
Most works
- Karen M. Mustian42 works
- Patrick M. Reagan37 works
- Olalekan O. Oluwole28 works
- Fergal J. Fleming28 works
- Kah Poh Loh26 works
- Richard G. Moore25 works
- Richard F. Dunne21 works
- David C. Linehan21 works
- Huina Zhang20 works
- Supriya G. Mohile20 works
Most cited
- Geriatric oncology
- Cancer control and survivorship (NCORP Research Base)
- Lymphoma
Similar pages
- Key paperGAP70+: a geriatric assessment before chemotherapy cut serious toxicity in older adults by a fifth
Shares Supriya G. Mohile, Geriatric assessment, Older and multimorbid patients are excluded and undertreated, Toxicity and quality of life are undervalued.
- IdeaCatch wasting early with a smart scale and a step counter
Shares Geriatric assessment, Exercise & lifestyle oncology, Toxicity and quality of life are undervalued.
- IdeaGeriatric assessment by default for every patient over 70 starting cancer treatment
Shares Geriatric assessment, Older and multimorbid patients are excluded and undertreated, Toxicity and quality of life are undervalued.
- TechnologyTai chi and qigong
Shares Geriatric assessment, Exercise & lifestyle oncology, Older and multimorbid patients are excluded and undertreated, Toxicity and quality of life are undervalued.
- IdeaPragmatic trials in patients over 75 with function, not just survival, as the primary endpoint
Shares Geriatric assessment, Older and multimorbid patients are excluded and undertreated.
- IdeaA defined pathway for patients with both dementia and cancer
Shares Geriatric assessment, Older and multimorbid patients are excluded and undertreated.
- IdeaGeriatrician co-management for older patients having cancer surgery
Shares Geriatric assessment, Older and multimorbid patients are excluded and undertreated.
- InstitutionEuropean Society for Clinical Nutrition and Metabolism
Shares Geriatric assessment, Exercise & lifestyle oncology, Older and multimorbid patients are excluded and undertreated.